">
Samsung Electronics Executive Chairman Lee Jae-yong had a round of meetings with global biopharmaceutical leaders to find a new growth engine beyond chips.
With inoculation rates high, Korea is struggling with a surplus of Covid-19 vaccines. Authorities are seeking to extend the shelf life of Pfizer and other vaccines by three months to use them as boosters, and looking for ways to send vaccines...
Moderna has joined forces with the International AIDS Vaccine Initiative (IAVI) in developing vaccines for highly infectious diseases that can be used in low-income countries.
Samsung Electronics Vice Chairman Lee Jae-yong met with the chief executives of Moderna and Verizon this week while in the United States, though it was not disclosed whether Lee will head to Texas to discuss a pending $17 billion chip deal there.
Korea is speeding up booster shots for the elderly, the sick, people in their 50s, soldiers, police and firefighters amid soaring infections and hospitalizations.
Around 2.4 million doses of Moderna’s Covid-19 vaccine packaged locally by the Korean drugmaker Samsung Biologics are to be used in Korea.
Korea will form a government-private committee to discuss strategies to return to normal life and will hold its first meeting this week in preparation of starting its "With Corona" plan in November.
Minors aged 12 to 17 and pregnant women will be eligible for Covid-19 vaccinations next month, and booster shots will be offered people over the age of 59 and front-line medical workers.
Prime Minister Kim Boo-kyum encouraged Samsung Biologics to take an active role in helping Korea achieve “vaccine sovereignty,” during his visit to the company's plant in Yeonsu District, Incheon, Friday.
After a summer of supply disruptions, Moderna vaccine shipments are set to resume with the arrival of 1,021,000 doses on Thursday, part of 6 million doses scheduled to land by Sunday.
Korea JoongAng Daily Sitemap